A meta-analysis of prospective, randomized controlled trials on novel oral anticoagulants
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …

Background: Based on the results from randomized controlled trials (RCTs), new oral
anticoagulants (NOACs) seem attractive alternatives to vitamin K antagonists (VKAs) …

Background and objective the study analysed the effectiveness and safety of warfarin use
compared with warfarin non-use and non-vitamin K antagonist oral anticoagulants (NOACs) …

Stroke prevention in very old patients with atrial fibrillation remains a challenge. There is a
high risk of systemic thromboembolism but also a high risk of bleeding if anticoagulants are …

Objective To evaluate the efficacy and safety of oral anticoagulants for older adult patients
with atrial fibrillation (AF). Design Pairwise and network meta-analyses. Setting and …

Background Frail patients with atrial fibrillation (AF) are thought to be at a higher risk for
cerebral infarction and death than patients who are not frail, making preventive interventions …

Aims The aim of the present meta-analysis was to evaluate the efficacy and safety of non-
vitamin K oral antagonists (NOACs) vs. vitamin K antagonists (VKAs) in elderly patients with …

Older people, are underrepresented in randomised controlled trials of direct oral
anticoagulants (DOACs) for stroke prevention in atrial fibrillation (AF). The aim of this study …

Elderly patients with atrial fibrillation are at a higher risk of both ischemic and bleeding
events compared with younger patients; therefore, balancing risks and benefits of …

Background: Stroke prevention with oral anticoagulants (OACs) is the cornerstone for the
management of atrial fibrillation (AF). However, data about the use of OACs among …